Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program (Q35073445)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program (English)

1 reference

Europe PubMed Central

6 August 2017

author name string

Hesselink AT

1

1 reference

Europe PubMed Central

6 August 2017

Bulkmans NW

2

1 reference

Europe PubMed Central

6 August 2017

Berkhof J

3

1 reference

Europe PubMed Central

6 August 2017

Lorincz AT

4

1 reference

Europe PubMed Central

6 August 2017

Meijer CJ

5

1 reference

Europe PubMed Central

6 August 2017

Snijders PJ

6

1 reference

Europe PubMed Central

6 August 2017

language of work or name

0 references

publication date

1 October 2006

1 reference

Europe PubMed Central

6 August 2017

Journal of Clinical Microbiology

1 reference

Europe PubMed Central

6 August 2017

44

1 reference

Europe PubMed Central

6 August 2017

10

1 reference

Europe PubMed Central

6 August 2017

3680-3685

1 reference

Europe PubMed Central

6 August 2017

Comparison of three different PCR methods for quantifying human papillomavirus type 16 DNA in cervical scrape specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

Management of women who test positive for high-risk types of human papillomavirus: the HART study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

The 2001 Bethesda System: terminology for reporting results of cervical cytology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

The causal relation between human papillomavirus and cervical cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

8 July 2018

Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

27 September 2018

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

27 September 2018

Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

27 September 2018

Interlaboratory reliability of Hybrid Capture 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

27 September 2018

Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

27 September 2018

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

27 September 2018

Human papillomavirus load in Hybrid Capture II assay: Does increasing the cutoff improve the test?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1594747

16 November 2018

Assessment of human papillomavirus mRNA detection over time in cervical specimens collected in liquid based cytology medium

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of high-risk HPV types by the hybrid capture 2 test

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types

1 reference

https://pubmed.ncbi.nlm.nih.gov/17021097

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/JCM.02078-05

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35073445&oldid=1568726984"